🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The CATARSIS study explores the use of anti-CD19 CAR T-cell therapy as a no...
Status
Recruiting
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Start Date
2024-11-29
Trial ID
NCT06685042
Treatments Being Tested
This Phase I/IIa clinical study is testing an experimental treatment called...
Status
Recruiting
Location
Hospital Clínic de Barcelona
Start Date
2026-02-04
Trial ID
NCT07471789
Treatments Being Tested
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
This is a clinical study of TAA6 cell injection in the treatment of patient...
Status
Unknown
Location
Anhui Provincial Hospital
Start Date
2019-12-09
Trial ID
NCT04692948
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficiency of autol...
Status
Active Not Recruiting
Location
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Start Date
2020-07-27
Trial ID
NCT04499573
Treatments Being Tested
This is a single-arm, open-label, phase I dose-escalation clinical study to...
Status
Recruiting
Location
Institute of Hematology & Blood Diseases Hospital, China
Start Date
2025-05-22
Trial ID
NCT06880354
Treatments Being Tested
Chimeric antigen receptor T cells (car-t) is one of the most effective ther...
Status
Completed
Location
No.3, Qingchun East Road
Start Date
2018-10-11
Trial ID
NCT04650724
Treatments Being Tested
Intravenous infusion of CART cells in the treatment of solid tumors may be ...
Status
Unknown
Location
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2016-03
Trial ID
NCT02715362
Treatments Being Tested
This trial aims to demonstrate the feasibility of this approach to reliably...
Status
Recruiting
Location
AHN Cancer Institute - West Penn Hospital
Start Date
2022-04-19
Trial ID
NCT05281809
Treatments Being Tested
A phase 1/2 study to assess the safety and efficacy of MB-102 in patients w...
Status
Terminated
Location
City of Hope Medical Center
Start Date
2020-02-17
Trial ID
NCT04109482
Treatments Being Tested